benzoyl peroxide 5%
Selected indexed studies
- Guidelines of care for the management of acne vulgaris. (J Am Acad Dermatol, 2024) [PMID:38300170]
- Adapalene/benzoyl peroxide gel 0.3%/2.5% for acne vulgaris. (Eur J Dermatol, 2022) [PMID:36301750]
- Sentiment Analysis of EPSOLAY (Microencapsulated Benzoyl Peroxide 5%) on Reddit: Pre- and Post-FDA Approval. (J Drugs Dermatol, 2024) [PMID:38834214]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Guidelines of care for the management of acne vulgaris. (2024) pubmed
- Adapalene/benzoyl peroxide gel 0.3%/2.5% for acne vulgaris. (2022) pubmed
- Ceramide-Containing Adjunctive Skin Care for Skin Barrier Restoration During Acne Vulgaris Treatment. (2023) pubmed
- Sentiment Analysis of EPSOLAY (Microencapsulated Benzoyl Peroxide 5%) on Reddit: Pre- and Post-FDA Approval. (2024) pubmed
- Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years. (2011) pubmed
- Adapalene 0.1% and benzoyl peroxide 2.5%: a novel combination for treatment of acne vulgaris. (2009) pubmed
- Epsolay™ (Microencapsulated Benzoyl Peroxide 5%) Cream for the Topical Treatment of Rosacea. (2023) pubmed
- Evaluation of the efficacy of maintenance therapy for acne vulgaris using adapalene 0.1%/benzoyl peroxide 2.5% gel and benzoyl peroxide 2.5% gel for 24 weeks and assessment of atrophic acne scars using three-dimensional image analysis. (2023) pubmed
- Meta-analysis of randomized controlled trials using 5% benzoyl peroxide and clindamycin versus 2.5% benzoyl peroxide and clindamycin topical treatments in acne. (2011) pubmed
- Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris. (1986) pubmed